MiRNA-200b-A Potential Biomarker Identified in a Porcine Model of Cardiogenic Shock and Mechanical Unloading

Overview

Journal Front Cardiovasc Med

Specialty Cardiology & Vascular Diseases

Date 2022 Jun 13

PMID 35694659

Authors

Christian Riehle

Jan-Thorben Sieweke

Sayan Bakshi

Chae-Myeong Ha

Nanna Louise Junker Udesen

Ole K Moller-Helgestad

Natali Froese

Hanne Berg Ravn

Heike Bahre

Robert Geffers

Roland Seifert

Jacob E Moller

Adam R Wende

Johann Bauersachs

Andreas Schafer

Affiliations

Soon will be listed here.

Abstract

Background: Cardiogenic shock (CS) alters whole body metabolism and circulating biomarkers serve as prognostic markers in CS patients. Percutaneous ventricular assist devices (pVADs) unload the left ventricle by actively ejecting blood into the aorta. The goal of the present study was to identify alterations in circulating metabolites and transcripts in a large animal model that might serve as potential prognostic biomarkers in acute CS and additional left ventricular unloading by Impella pVAD support.

Methods: CS was induced in a preclinical large animal model by injecting microspheres into the left coronary artery system in six pigs. After the induction of CS, mechanical pVAD support was implemented for 30 min total. Serum samples were collected under basal conditions, after the onset of CS, and following additional pVAD unloading. Circulating metabolites were determined by metabolomic analysis, circulating RNA entities by RNA sequencing.

Results: CS and additional pVAD support alter the abundance of circulating metabolites involved in Aminoacyl-tRNA biosynthesis and amino acid metabolism. RNA sequencing revealed decreased abundance of the hypoxia sensitive miRNA-200b following the induction of CS, which was reversed following pVAD support.

Conclusion: The hypoxamir miRNA-200b is a potential circulating marker that is repressed in CS and is restored following pVAD support. The early transcriptional response with increased miRNA-200b expression following only 30 min of pVAD support suggests that mechanical unloading alters whole body metabolism. Future studies are required to delineate the impact of serum miRNA-200b levels as a prognostic marker in patients with acute CS and pVAD unloading.

Citing Articles

Animal Models for Mechanical Circulatory Support: A Research Review.

Orgil B, Chintanaphol M, Alberson N, Letourneau L, Martinez H, Towbin J Rev Cardiovasc Med. 2024; 25(10):351.

PMID: 39484122 PMC: 11522838. DOI: 10.31083/j.rcm2510351.

Altered MicroRNA Maturation in Ischemic Hearts: Implication of Hypoxia on XPO5 and DICER1 Dysregulation and RedoximiR State.

Perez-Carrillo L, Gimenez-Escamilla I, Garcia-Manzanares M, Trivino J, Feijoo-Bandin S, Aragon-Herrera A Antioxidants (Basel). 2023; 12(7).

PMID: 37507877 PMC: 10376795. DOI: 10.3390/antiox12071337.

Vitamin A preserves cardiac energetic gene expression in a murine model of diet-induced obesity.

Naasner L, Froese N, Hofmann W, Galuppo P, Werlein C, Shymotiuk I Am J Physiol Heart Circ Physiol. 2022; 323(6):H1352-H1364.

PMID: 36399384 PMC: 11687967. DOI: 10.1152/ajpheart.00514.2022.

References

Udesen N, Helgestad O, Banke A, Frederiksen P, Josiassen J, Jensen L . Impact of concomitant vasoactive treatment and mechanical left ventricular unloading in a porcine model of profound cardiogenic shock. Crit Care. 2020; 24(1):95. PMC: 7079533. DOI: 10.1186/s13054-020-2816-8. View

Ibanez B, James S, Agewall S, Antunes M, Bucciarelli-Ducci C, Bueno H . 2017 ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: The Task Force for the management of acute myocardial infarction in patients presenting with ST-segment elevation of the European.... Eur Heart J. 2017; 39(2):119-177. DOI: 10.1093/eurheartj/ehx393. View

Mierzchala-Pasierb M, Lipinska-Gediga M, Fleszar M, Lesnik P, Placzkowska S, Serek P . Altered profiles of serum amino acids in patients with sepsis and septic shock - Preliminary findings. Arch Biochem Biophys. 2020; 691:108508. DOI: 10.1016/j.abb.2020.108508. View

Moller-Helgestad O, Hyldebrandt J, Banke A, Rud C, Udesen N, Linde L . Impella CP or VA-ECMO in profound cardiogenic shock: left ventricular unloading and organ perfusion in a large animal model. EuroIntervention. 2018; 14(15):e1585-e1592. DOI: 10.4244/EIJ-D-18-00684. View

Magenta A, Cencioni C, Fasanaro P, Zaccagnini G, Greco S, Sarra-Ferraris G . miR-200c is upregulated by oxidative stress and induces endothelial cell apoptosis and senescence via ZEB1 inhibition. Cell Death Differ. 2011; 18(10):1628-39. PMC: 3172120. DOI: 10.1038/cdd.2011.42. View

Lee S, Chu K, Jung K, Yoon H, Jeon D, Kang K . MicroRNAs induced during ischemic preconditioning. Stroke. 2010; 41(8):1646-51. DOI: 10.1161/STROKEAHA.110.579649. View

Moller-Helgestad O, Poulsen C, Christiansen E, Lassen J, Ravn H . Support with intra-aortic balloon pump vs. Impella2.5® and blood flow to the heart, brain and kidneys - an experimental porcine model of ischaemic heart failure. Int J Cardiol. 2014; 178:153-8. DOI: 10.1016/j.ijcard.2014.10.153. View

Chan Y, Khanna S, Roy S, Sen C . miR-200b targets Ets-1 and is down-regulated by hypoxia to induce angiogenic response of endothelial cells. J Biol Chem. 2010; 286(3):2047-56. PMC: 3023502. DOI: 10.1074/jbc.M110.158790. View

Bar C, Chatterjee S, Thum T . Long Noncoding RNAs in Cardiovascular Pathology, Diagnosis, and Therapy. Circulation. 2016; 134(19):1484-1499. DOI: 10.1161/CIRCULATIONAHA.116.023686. View

10.

Greco S, Gaetano C, Martelli F . HypoxamiR regulation and function in ischemic cardiovascular diseases. Antioxid Redox Signal. 2013; 21(8):1202-19. PMC: 4142792. DOI: 10.1089/ars.2013.5403. View

11.

Udesen N, Moller J, Lindholm M, Eiskjaer H, Schafer A, Werner N . Rationale and design of DanGer shock: Danish-German cardiogenic shock trial. Am Heart J. 2019; 214:60-68. DOI: 10.1016/j.ahj.2019.04.019. View

12.

Schafer A, Werner N, Burkhoff D, Sieweke J, Zietzer A, Masyuk M . Influence of Timing and Predicted Risk on Mortality in Impella-Treated Infarct-Related Cardiogenic Shock Patients. Front Cardiovasc Med. 2020; 7:74. PMC: 7240000. DOI: 10.3389/fcvm.2020.00074. View

13.

Cambiaghi A, Pinto B, Brunelli L, Falcetta F, Aletti F, Bendjelid K . Characterization of a metabolomic profile associated with responsiveness to therapy in the acute phase of septic shock. Sci Rep. 2017; 7(1):9748. PMC: 5575075. DOI: 10.1038/s41598-017-09619-x. View

14.

Sieweke J, Berliner D, Tongers J, Napp L, Flierl U, Zauner F . Mortality in patients with cardiogenic shock treated with the Impella CP microaxial pump for isolated left ventricular failure. Eur Heart J Acute Cardiovasc Care. 2018; 9(2):138-148. DOI: 10.1177/2048872618757393. View

15.

Bartoszewska S, Kochan K, Piotrowski A, Kamysz W, Ochocka R, Collawn J . The hypoxia-inducible miR-429 regulates hypoxia-inducible factor-1α expression in human endothelial cells through a negative feedback loop. FASEB J. 2015; 29(4):1467-79. PMC: 4396612. DOI: 10.1096/fj.14-267054. View

16.

Thiele H, Zeymer U, Neumann F, Ferenc M, Olbrich H, Hausleiter J . Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012; 367(14):1287-96. DOI: 10.1056/NEJMoa1208410. View

17.

Sieweke J, Pfeffer T, Berliner D, Konig T, Hallbaum M, Napp L . Cardiogenic shock complicating peripartum cardiomyopathy: Importance of early left ventricular unloading and bromocriptine therapy. Eur Heart J Acute Cardiovasc Care. 2018; 9(2):173-182. DOI: 10.1177/2048872618777876. View

18.

Iborra-Egea O, Rueda F, Garcia-Garcia C, Borras E, Sabido E, Bayes-Genis A . Molecular signature of cardiogenic shock. Eur Heart J. 2019; 41(39):3839-3848. DOI: 10.1093/eurheartj/ehz783. View

19.

Sieweke J, Akin M, Beheshty J, Flierl U, Bauersachs J, Schafer A . Unloading in Refractory Cardiogenic Shock After Out-Of-Hospital Cardiac Arrest Due to Acute Myocardial Infarction-A Propensity Score-Matched Analysis. Front Cardiovasc Med. 2021; 8:704312. PMC: 8421736. DOI: 10.3389/fcvm.2021.704312. View

20.

Goldberg R, Spencer F, Gore J, Lessard D, Yarzebski J . Thirty-year trends (1975 to 2005) in the magnitude of, management of, and hospital death rates associated with cardiogenic shock in patients with acute myocardial infarction: a population-based perspective. Circulation. 2009; 119(9):1211-9. PMC: 2730832. DOI: 10.1161/CIRCULATIONAHA.108.814947. View